1. Home
  2. AUB vs CRSP Comparison

AUB vs CRSP Comparison

Compare AUB & CRSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Atlantic Union Bankshares Corporation

AUB

Atlantic Union Bankshares Corporation

HOLD

Current Price

$38.81

Market Cap

6.0B

Sector

Finance

ML Signal

HOLD

CRSP

CRISPR Therapeutics AG

HOLD

Current Price

$56.48

Market Cap

5.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AUB
CRSP
Founded
1902
2013
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.0B
5.8B
IPO Year
2005
2016

Fundamental Metrics

Financial Performance
Metric
AUB
CRSP
Price
$38.81
$56.48
Analyst Decision
Strong Buy
Buy
Analyst Count
8
17
Target Price
$41.88
$70.29
AVG Volume (30 Days)
962.7K
1.4M
Earning Date
04-21-2026
05-11-2026
Dividend Yield
3.98%
N/A
EPS Growth
N/A
N/A
EPS
1.95
N/A
Revenue
N/A
$289,590,000.00
Revenue This Year
$29.16
$807.72
Revenue Next Year
$4.59
$172.52
P/E Ratio
$19.98
N/A
Revenue Growth
N/A
9169.85
52 Week Low
$30.87
$44.12
52 Week High
$43.62
$78.48

Technical Indicators

Market Signals
Indicator
AUB
CRSP
Relative Strength Index (RSI) 32.33 54.20
Support Level $38.29 $50.45
Resistance Level $38.77 $60.50
Average True Range (ATR) 0.79 2.30
MACD -0.11 -0.16
Stochastic Oscillator 10.14 61.19

Price Performance

Historical Comparison
AUB
CRSP

About AUB Atlantic Union Bankshares Corporation

Atlantic Union Bankshares Corp is a financial and bank holding company based in the U.S. Through its community bank subsidiary and non-bank financial services affiliates, the company provides financial services, including banking, trust, and wealth management. It offers consumers and businesses a wide range of banking and related financial services, including checking, savings, certificates of deposit, and other depository services, as well as loans for commercial, industrial, residential mortgage, and consumer purposes. The company operates through two reportable operating segments: Wholesale Banking and Consumer Banking, with corporate support functions such as corporate treasury and others included in Corporate Other. It derives maximum revenue from the Wholesale Banking segment.

About CRSP CRISPR Therapeutics AG

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.

Share on Social Networks: